Table 6.
Association of receipt of high quality chronic disease managementand utilization of specialty addictiontreatment, addiction pharmacotherapy, and mutualhelp group a
| Specialty addiction treatment Global p-value AOR (95% CI) |
Addiction pharmacotherapy Global p-value AOR (95% CI) |
Mutualhelp12-step group Global p-value AOR (95% CI) |
||||
|---|---|---|---|---|---|---|
| Engagement with CCDM |
||||||
| Yes | 0.001 | 2.34 (1.51, 3.64) | 0.0008 | 3.55 (2.02, 6.25) | 0.2 | 1.18 (0.74, 1.87) |
| No | 1.24 (0.94, 1.64) | 1.50 (0.99, 2.27) | 0.81 (0.59, 1.09) | |||
| Control | 1 | 1 | 1 | |||
| PACIC-CDM clinic(tertiles) |
||||||
| Highest | 0.004 | 2.13 (1.31, 3.45) | 0.5 | 1.33 (0.70, 2.49) | 0.02 | 1.88 (1.12, 3.14) |
| Middle | 2.00 (1.21, 3.30) | 0.93 (0.49, 1.76) | 2.09 (1.22, 3.60) | |||
| Lowest | 1 | 1 | 1 | |||
| PACIC-any (tertiles) |
||||||
| Highest | 0.002 | 1.83 (1.30, 2.59) | 0.4 | 1.37 (0.84, 2.26) | 0.007 | 1.86 (1.26, 2.75) |
| Middle | 1.18 (0.83, 1.67) | 1.27 (0.77, 2.09) | 1.49 (1.02, 2.18) | |||
| Lowest | 1 | 1 | 1 | |||
Results of separate multivariable logistic regression models for each outcome and each main independent variable.
Specialty addiction treatment defined as outpatient or inpatient addiction treatment excluding detoxification;addiction pharmacotherapyas medication to prevent drinking or drug use, help cut-down, or quit (not for detoxification);and mutual help, 12-step (e.g., AA) groups.
All models include age, sex, race/ethnicity and the following time-varying covariates: homeless (Y/N), depression (PHQ-9), alcohol and drug severity, time since study enrollment (3,6, or 12 months).
Analytic sample sizes: Engagement with CDM clinic care = 553 PACIC-CDM clinic = 249 PACIC-any = 451